At Scifiniti, our editorial policies ensure the highest standards of integrity, transparency, and fairness in scholarly publishing. These policies define the roles and responsibilities of editors, reviewers, and authors, guiding all decisions from submission to post-publication.
This page outlines our core principles, including editorial independence, peer review, conflict of interest management, ethical oversight, and AI use. For detailed guidance on research and publication ethics, please refer to our Publication Ethics and Integrity Guidelines
At Scifiniti, we uphold the principle of full editorial independence. All decisions regarding manuscript acceptance, peer review, and publication are made solely by the Editor-in-Chief, free from any influence of financial, commercial, or institutional pressures. As a publisher, we do not interfere with editorial judgments, ensuring that content is evaluated and published strictly on the basis of scholarly merit, scientific rigor, and editorial excellence.
Scifiniti follows the guidelines set forth by COPE on editorial independence. To review COPE’s position statement, please see COPE Guidance on Editorial Independence
Scifiniti abides by the guidelines recommended by the ICMJE and COPE for authorship criteria. To become an author, an individual must follow the four criteria stated by ICMJE:
Authors’ contributions toward the preparation of manuscripts must be properly mentioned in the manuscript. Authors are recommended to refer to CRediT (Contributor Roles Taxonomy), which offers a comprehensive taxonomy encompassing 14 distinct roles that characterize contributors' involvement in research outputs. These roles serve to specify the contributions made by each author to the article.
It is recommended that individuals who do not meet all the specified criteria for authorship should not be included as authors in the paper. Instead, their contributions should be acknowledged in the Acknowledgment section of the manuscript. This practice is in line with the recommendations from organizations such as the ICMJE and the COPE. Before proceeding with acknowledgments, it is essential to ensure the approval of the corresponding author and to adhere to the specific authorship and acknowledgments policies of the target journal to maintain transparency and ethical standards in scholarly publishing.
The following activities alone, without additional substantial contribution, don’t meet authorship criteria:
As per the recommended guidelines of ICMJE, because acknowledgment may imply endorsement of a study’s data and conclusions, we require that the corresponding author obtain written permission from all individuals listed in the acknowledgments.
For further details, please review ICMJE's definition of non-author contribution.
The corresponding author is the primary author responsible for coordinating with the Editorial Office throughout the manuscript processing, from submission to publication. They act as the main liaison between the co-authors and the journal, keeping all authors informed of manuscript status, editorial decisions, and reviewer comments. The corresponding author is also the point of contact after publication for any queries related to the manuscript, including requests for corrections, clarifications, or additional information. They ensure that all important updates are communicated to the co-authors and that the published record accurately reflects the work
A co-author is an individual who makes substantial contributions to the conception, design, methodology, execution, investigation, or analysis of the research presented. Co-authors are expected to participate in drafting or critically revising the manuscript, approve the final version for publication, and take responsibility for the integrity of their contribution. All co-authors share accountability for ensuring the accuracy and ethical compliance of the work.
In the case of manuscripts where authorship is retained by a consortium or group, the author list must include the name of the consortium or group only if all listed individual authors meet all four ICMJE authorship criteria as described above.
If an author passes away during the manuscript processing stage, it is the responsibility of the corresponding author or co-authors to notify the editorial office. In cases where the deceased author was the corresponding author, the remaining authors, by mutual consent, should nominate another author to assume this role. The newly appointed corresponding author must ensure that the deceased author’s conflict of interest (COI) statement has been addressed. If necessary, the corresponding author may obtain confirmation of the COI from the author’s next of kin, family member, or legal executor. The editorial office should be informed, and the name of the newly appointed corresponding author should be appended to the manuscript following publication. The deceased author will still be eligible to be listed as an author if they have made a substantial contribution to the work, ensuring proper recognition of their scientific contribution.
If the manuscript has only a single author who passes away, and all revisions were confirmed by the author before their death, the final approval of the publisher’s version may be provided by the author’s next of kin or legal executor. Any comments or feedback from the next of kin will be recorded and considered by the editorial office before publication.
For transparency, the journal includes a statement or footnote in the published article indicating the date of the author’s death in relation to their participation in authorship, along with a note that, to the best of the journal’s ability, there were no conflicts of interest affecting the work.
In the published manuscript, a toggle symbol (†) will be placed next to the name of the deceased author. A corresponding note will indicate:
This ensures that deceased authors receive proper acknowledgments for their contributions, maintains transparency for readers, and preserves the integrity of the scientific record.
Scifiniti acknowledges that AI tools may support manuscript preparation. AI tools cannot be credited as authors, as they cannot take responsibility for the work, disclose conflicts of interest, or manage copyright and licensing. Authors remain entirely responsible for the integrity, originality, and accuracy of all content, including sections generated with AI. For comprehensive guidance, please refer to the AI Usage Policy section.
Gift authorship, also known as honorary authorship, involves individuals who have made no significant contribution to the preparation of the manuscript. There could be several reasons to include a guest author, such as establishing credibility or satisfying institutional or publication requirements.
Similarly, Guest authorship is an authorship with no contribution in manuscript preparation, but their names are added for courtesy, gratitude, or other non-substantive reasons.
Scifiniti strictly adheres to ICMJE authorship criteria and does not permit gift or guest authorship under any circumstances.
In contrast to gift and guest authors, ghost authors are those who have made significant contributions to the manuscript's preparation, but their names are not listed in the authorship. Instead, their contribution has been attributed to someone else in the manuscript.
Identifying guest, gift, and ghost authors is sometimes difficult. Scifiniti therefore follows COPE Guidelines to identify such authorship problems. If such authorship issues are identified, appropriate actions as recommended by COPE will be taken.
The number of authors on a manuscript may range from a sole author to multiple contributors, with no restriction on total authorship. The order of authors should reflect each individual’s relative contribution or be mutually agreed upon by all authors.
Any change in the authors’ list, including changes in sequence, addition, or removal of authors during or after the publication of the manuscript, must be approved by all listed authors. The corresponding author is required to provide:
Scifiniti however, reserves the right to accept or reject modification based on provided evidence, and in this connection, the COPE recommended protocol will be used:
For comprehensive information on Authorship, please review “COPE Discussion Document on Authorship”.
Authorship disputes may occur when disagreements arise among contributors regarding their roles, responsibilities, or recognition in a manuscript. These disputes generally fall into two categories:
Authorship disputes, if they occur, are addressed in accordance with the guidelines recommended by the COPE. Generally, disputed authorship does not justify retraction as long as there is no valid reason to question the validity of the findings.
Plagiarism, the act of using someone else's work without proper attribution, is strictly prohibited within Scifiniti's publishing guidelines. Authors are strongly advised to submit only original manuscripts, ensuring that their work is a genuine contribution to the academic discourse.
Scifiniti employs professional plagiarism detection software to uphold the integrity of the peer review process. This software meticulously examines submitted manuscripts for any instances of plagiarism. In the event that plagiarism is identified during the peer review process, the manuscript will be subject to further evaluation. The decision of whether to reject the manuscript outright or request revisions will be made after a comprehensive content assessment, going beyond a mere percentage review.
It is essential to note that if plagiarism is detected after publication, it may result in the retraction of the manuscript. Authors are, therefore, strongly urged to diligently check their manuscripts using any reputable plagiarism detection tool before submission. This precautionary measure aims to prevent rejection due to similarities in content and ensures the scholarly integrity of the publications associated with Scifiniti.
Scifiniti strictly follows COPE guidelines to deal with cases of plagiarism.
Similarly, image files must remain unaltered or modified in such a way that could not change the information of the original image. These inappropriate modifications include modifying any of the features of the image, combining it with any other image, enhancing brightness, contrast, colour balance, etc. If image manipulation is found during the peer review process, then the manuscript will either be rejected or modified. If image manipulation is found after publication, then it will be handled, as per the suggested protocol of COPE.
The following are the useful links on image manipulation:
At Scifiniti, we are committed to a rigorous, transparent, and unbiased peer review process. All manuscripts undergo evaluation by independent experts to ensure scientific quality, originality, and ethical compliance. Reviewers are selected based on their expertise and are screened to avoid conflicts of interest with authors.
We uphold the principles of confidentiality, fairness, and timely evaluation throughout the review process. For detailed information about our peer review workflow, reviewer responsibilities, and standards, please see our Peer Review Process
With rapid advances in technology, Artificial Intelligence (AI) and AI-assisted tools are increasingly being used in research and scholarly writing. When applied responsibly, these tools can help researchers work efficiently, analyze complex literature, summarize a field or research question, identify gaps, generate ideas, and support tasks such as organizing content and refining language for clarity.
Scifiniti Publishing recognizes the value of these tools but emphasizes that human oversight, critical thinking, and subject-matter expertise remain essential. AI outputs cannot substitute human evaluation, interpretation, or judgment, and authors remain fully accountable for the integrity and accuracy of their work.
Scifiniti strongly adheres to the industry best practices and in accordance with the COPE statement regarding the use of AI in manuscripts. AI tools, including but not limited to large language models (LLMs), image generators, translation/writing assistants cannot take responsibility for submitted work, declare conflicts of interest, or manage copyright and licensing agreements, and therefore cannot be listed as authors.
Guidelines for AI Use
a): AI as Assistance Only
AI tools may support manuscript preparation, research synthesis, or writing tasks. However, all AI-generated content must be thoroughly checked, validated, and revised by the authors. The final manuscript must reflect the authors’ own ideas, analysis, and interpretations. AI cannot replace human critical thinking or scholarly judgment.
b): Accountability
Authors are fully responsible for their work. This includes:
c): Editing and Adaptation
AI-generated material must be carefully adapted to reflect the authors’ own analysis, interpretations, and expertise. The final manuscript should demonstrate the authors’ intellectual contribution, rather than reliance on AI outputs.
d): Responsible Use and Data Privacy
Authors must use AI tools responsibly and ethically, ensuring compliance with data privacy, intellectual property, and other legal requirements. Before using any AI tool, authors should:
e): Disclosure
The use of AI tools must be transparently disclosed either:
Authors should document:
Routine grammar, spelling, or formatting corrections performed by AI do not require disclosure.
f): Authorship
AI tools cannot be credited as authors, as they cannot assume responsibility, approve the final manuscript, declare conflicts of interest, or manage copyright and licensing matters. Authorship is reserved for humans who can take full accountability for the work.
g): Ethics and Integrity
Authors are responsible for ensuring the transparency, originality, and integrity of their work, including AI-assisted content. Manuscripts must comply with publication ethics, including plagiarism, originality, and data integrity standards.
h): Peer Review and Safeguards
If involved in peer review, authors and reviewers must ensure that manuscripts or unpublished content are not uploaded into AI tools without proper safeguards.
Scifiniti recognizes the growing role of generative artificial intelligence (AI) in creating visual content and is committed to ensuring transparency, research integrity, and ethical compliance in all submissions. AI-generated images may be used only for illustrative purposes, such as:
These images must not represent primary research data or experimental findings. Their purpose is to enhance comprehension and visualization, not to substitute for authentic experimental results.
AI-generated images must never be used to:
Authors remain fully responsible for the integrity, reproducibility, and accuracy of all content submitted.
When AI-generated images are included, authors must provide a clear disclosure stating:
In addition to the above declaration, any AI-generated or AI-assisted image must be labeled in the caption as “AI-generated/AI-assisted image.”
Authors are responsible for ensuring:
Scifiniti assumes no liability for copyright disputes arising from improper use of AI-generated content. The editorial office reserves the right to:
If the editorial office identifies concerns regarding potential AI-generated images, the authors will be notified and given an opportunity to respond and provide clarification before any further action is taken.
When Scifiniti invites a reviewer to review a manuscript, reviewers are required to maintain strict confidentiality. Manuscripts must never be shared with third parties or uploaded to any AI tools or external platforms, as this would violate the journal’s privacy policies, author confidentiality, and copyright regulations.
Reviewers are expected to assess the manuscript solely based on their expertise and judgment. If reviewers suspect any AI-generated content in the manuscript, they should contact the editorial office for guidance rather than analyzing the manuscript through external AI tools.
Limited use of AI tools is permitted only for preparing the reviewer’s own report, such as improving grammar, spelling, punctuation, or clarity. Under any circumstances, the manuscript itself must never be uploaded to any AI tool. Also, reviewers are recommended to disclose the use of AI (if used) in preparing the review when submitting the report. AI tools cannot be used to assess, interpret, or judge any part of the manuscript.
Reviewers are strongly encouraged to follow these guidelines strictly to preserve the integrity, confidentiality, and ethical standards of the peer review process.
Editors are entrusted with maintaining the highest standards of confidentiality, integrity, and professional judgment throughout the editorial process.
Editors are strictly prohibited from using AI tools to evaluate, assess, or make any editorial decisions regarding submitted manuscripts. All decisions ABOUT revision, acceptance, or rejection must be based solely on the editor’s independent expertise and professional judgment.
Manuscripts under consideration are confidential documents. Editors must not upload manuscripts, reviewer reports, or any portion of submission content to external AI tools or platforms, as doing so may breach confidentiality, copyright, and data protection obligations.
Limited use of AI tools may be permitted only for linguistic or administrative assistance, such as improving grammar, spelling, clarity, or formatting in editorial correspondence. AI tools must not influence or contribute to the scientific assessment, ethical evaluation, or decision-making process.
Editors may use AI tools that are officially provided or approved by Scifiniti, provided that such tools operate within the publisher’s secure environment and comply with confidentiality and data protection standards.
Editors are strongly required to adhere strictly to this policy to preserve the integrity, confidentiality, and independence of the editorial process.
Scifiniti is committed to maintaining high standards of research integrity, confidentiality, and quality assurance. In support of these standards, we use carefully selected and secure tools within our publishing workflow.
5.4.1. Similarity and AI Content Screening
Scifiniti Publishing uses the Crossref Similarity Check service powered by iThenticate to screen submitted manuscripts for textual similarity. The same system is also used for AI-content detection functionalities available within iThenticate. These tools assist the editorial office in identifying potential overlap or AI-generated patterns; however, all reports are carefully reviewed and interpreted by qualified editorial staff.
If concerns arise regarding possible AI-generated images or undisclosed AI use, the authors will be informed and given an opportunity to respond and provide clarification before any further editorial action is taken.
5.4.2. Reviewer Selection Tools
Scifiniti utilizes reviewer recommendation tools integrated within our manuscript submission platform to support reviewer selection.
These tools provide suggestions based on subject relevance; however, reviewer expertise, academic credentials, publication record, and suitability are independently verified by the editorial team before assignment. Editorial judgment remains central to the reviewer selection process.
5.4.3. Language and Production Support
After final acceptance of a manuscript, Scifiniti Publishing may use language-support tools such as Grammarly to improve grammar, clarity, and readability. Language tools are used only to enhance linguistic quality and must not alter the scientific meaning of the content.
All suggested changes are carefully reviewed and monitored by our in-house production editors to ensure accuracy and preservation of the authors’ intended meaning. If any substantive edits are required, they are communicated to the authors for review and approval.
5.4.4. XML Conversion and Technical Processing
Scifiniti uses automated XML conversion tools during the production stage to facilitate indexing, archiving, and online publication formatting. These tools support technical structuring only and do not alter the scientific content of the manuscript.
Scifiniti ensures that all automated and AI-supported tools are used within secure environments and under strict editorial oversight. AI systems are employed solely to support efficiency and quality control, and they do not replace human editorial judgment or decision-making at any stage of the publishing process.
As a scientific publisher, we maintain a strong commitment to upholding the highest standards of integrity, objectivity, and transparency in the dissemination of scientific knowledge. We recognize the importance of managing potential conflicts of interest to safeguard the integrity of the research and scholarly content we publish. Authors are strongly recommended to disclose any potential conflict of interest in their manuscripts under the section “Conflicts of Interest”.
Scifiniti follows COPE’s recommendation to deal with undisclosed conflict of interest cases before or after the publication.
When documenting research that involves human subjects, human materials, human tissues, or human data, it is imperative for authors to state that the research adhered to the principles outlined in the Declaration of Helsinki of 1975 (revised in 2013). More information about the Declaration of Helsinki can be found at https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/.
According to point 23 of this declaration, “The research protocol must be submitted for consideration, comment, guidance, and approval to the concerned research ethics committee before the study begins. This committee must be transparent in its functioning, must be independent of the researcher, the sponsor, and any other undue influence, and must be duly qualified. It must take into consideration the laws and regulations of the country or countries in which the research is to be performed as well as applicable international norms and standards but these must not be allowed to reduce or eliminate any of the protections for research subjects set forth in this Declaration.
The committee must have the right to monitor ongoing studies. The researcher must provide monitoring information to the committee, especially information about any serious adverse events. No amendment to the protocol may be made without consideration and approval by the committee. After the end of the study, the researchers must submit a final report to the committee containing a summary of the study’s findings and conclusions.”
Authors are recommended to provide a separate section for Human rights and mention clearly that research has been conducted by the Declaration of Helsinki, along with the identification code and name of the Ethics Committee that has approved the protocol.
We expect authors should follow the Animal Use Alternatives (3Rs) model while conducting any research that requires the use of animals. These new scientific approaches proposed by Drs. William Russell and Rex Burch, help to minimize to maintain scientific integrity by reducing the pain and distress of research animals.
We recommend authors follow the “Basel Declaration” which summarizes essential principles to follow when conducting research in animals. The International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines that could help authors protect animal rights while conducting any research.
Authors are required to explicitly mention the name of the approval committee and reference number in their manuscript, emphasizing that they obtained both legal and ethical approval before commencing the research involving animals. Additionally, the authors must affirm that the experiments were conducted in strict adherence to the guidelines outlined below.
If ethical approval is exempted from any committee then this should also be clearly mentioned in the manuscripts along with the name of the committee that grants exemption.
Scifiniti recommends authors use ARRIVE guidelines for reporting research involving animals. Reviewers are also recommended to use CHECKLIST while reviewing a manuscript and provide their recommendations if the research is not in compliance with any of the points mentioned in the checklist.
For in vivo experiments, visit https://www.nc3rs.org.uk/arrive-guidelines
Experimental research on plants must be conducted in compliance with relevant guidelines published by the IUCN Policy Statement on Research Involving Species at Risk of Extinction, the Convention on Biological Diversity, and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.
Authors are advised to provide ethical statements including the name and source of the plant used during research.
Example: Solanum tubersum was used in conducting research which was provided by Dr. (XYZ), affiliation, City, Country.
To support reproducibility, voucher specimens of rare and non-model plants must be deposited in a publicly accessible herbarium, public museum or another public repository. These vouchers should include documentation of specific parts of the plants which are used in the research, details of the geographical coordinates of the collection site and the collection date.
If a research involves the use of cell lines then authors should mention the origin in the methods sections of their manuscript. If an author has used established cell lines then the source and reference of the published article should be mentioned. For previously unpublished de novo cell lines, details of the ethical committee and approval should be mentioned in the manuscript. Informed consent must be taken in cases where human cell lines are used.
Example: The HaCaT cell lines were provided by XYZ
For misidentification and contamination of human cell lines, please International Cell Line Authentication Committee (ICLAC) and NCBI database.
For use, ISSCR Guidelines for Stem Cell Research and Clinical Translation should be followed for reporting experiments on human embryos, gametes and embryonic stem cells.
If authors have used details, images, or videos of a person, then written consent from the relevant individual must also be taken to publish under Creative Commons Attribution License 4.0. If an individual is under 18 then parents or legal guardians must be contacted for their consent to publish data. Personal identifiers, such as names, initials, or hospital numbers, should not be disclosed in the manuscript unless it is indispensable for scientific purposes.
In cases where an individual has passed away, it is necessary to seek consent for publication from their immediate family or next of kin. The manuscript should incorporate a declaration confirming that written informed consent for publication has been secured.
For unidentified images like X-rays, ultrasound images, etc., no consent for publication is needed.
For further details, ICMJE recommendations for “Protection of Research Participants”.
Scifiniti strongly recommends its authors follow ICMJE's recommendations for registration of clinical trials in a public trials registry. They are also recommended to cite it as a reference in their manuscript.
According to WHO “a clinical trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes. Clinical trials may also be referred to as interventional trials. Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioural treatments, process-of-care changes, preventive care, etc.” This definition includes Phase I to Phase IV trials."
In line with the position of ICMJE, Scifiniti strongly encourages authors to include a statement in their manuscript that the results are unpublished in a peer-reviewed journal; this information can however be updated as results are published.
Scifiniti recommends CONSORT for randomised controlled trials; authors submit CONSORT checklist and Protocol Flow Diagram during manuscript submission.
Authors are advised to follow ‘Sex and Gender Equity in Research – SAGER – guidelines’. Authors should ensure that the terms sex (referring to a biological attribute) and gender (influenced by social and cultural factors) are used carefully in order to avoid confusion in the two terms. In the introduction, authors should consider discussing the potential presence of sex and/or gender differences. Furthermore, they should detail the methods used to address sex and/or gender in the study's design and present data separated by sex and/or gender when it is relevant. Authors should also analyze and present results specific to each sex and/or gender group. If the study did not include a sex and/or gender analysis, the authors should provide a justification in the discussion. We recommend that our authors refer to the comprehensive guidelines before submitting their work.
Scifiniti is committed to addressing ethical complaints in a timely and transparent manner. Individuals concerned about ethical issues in a published or submitted manuscript can contact the editorial office. The complainant should outline their concerns with supporting evidence, and their identity will be kept confidential.
Upon receiving a complaint, the editorial office will initiate an investigation in line with COPE guidelines. The involved parties, including authors, reviewers, and editors, may be contacted for clarification during this process. Depending on the findings, appropriate actions will be taken, which may include corrections, retractions, or sanctions against individuals found in violation of ethical standards.
For post-publication corrections, errors or inaccuracies discovered after publication will be promptly addressed to maintain the integrity of the scholarly record. Post-publication updates may include errata, corrigenda, retractions, withdrawals, editor’s notes, or editorial expressions of concern, depending on the issue. The corresponding author should contact the editorial office with a detailed explanation of the error, and corrections will be made following COPE guidelines.
An erratum is published when a manuscript contains minor errors that do not involve ethical concerns and do not affect the overall integrity or conclusions of the article. These are typically errors introduced during editing or production and may be identified by the publisher, authors, or readers after publication. A DOI will be assigned to the erratum, which will be linked to the original article, along with a publisher’s note explaining the correction.
A corrigendum is published when an author identifies an error in their article after publication. The author should prepare a note describing the error, which must be signed and confirmed by all co-authors. A DOI will be assigned to the corrigendum, linking it to the original article.
A corrigendum is appropriate only for errors that do not invalidate the main results or conclusions of the article. Errors affecting the validity of the study require alternative corrective actions, such as retraction.
Authors may request the withdrawal of a manuscript prior to its acceptance for publication. However, withdrawal after acceptance or publication is strongly discouraged and permitted only for compelling, integrity‑related reasons such as ethical concerns (e.g., errors affecting validity, authorship disputes, plagiarism, or other serious issues). Withdrawal requests must be supported by a clear explanation of the reason and approved by the Publisher.
In addition to author-initiated withdrawals, the journal reserves the right to issue a withdrawal if the Editorial Office identifies substantial concerns at the pre-publication or Early Access stage that could compromise the integrity of the manuscript. In such cases, a formal post-publication withdrawal notice will be issued to ensure transparency and maintain the scholarly record.
If a DOI has already been assigned and the manuscript is published online as an Early Access article (or similar), the article’s content (PDF and HTML) will not simply be removed. Instead:
The original article files will be replaced with a formal withdrawal notice that clearly explains the reason for withdrawal.
The DOI will remain active and will redirect to the withdrawal notice page.
This approach aligns with international publishing best practices and ensures the integrity and permanence of the scholarly record while transparently documenting reasons for withdrawal.
In cases where a published article is found to contain serious ethical issues, data fabrication, or other forms of misconduct, a retraction may be necessary to maintain the integrity of the scholarly record. Retractions can be initiated by the authors, editors, or the Publisher. Author-initiated retractions typically occur when authors identify significant errors that invalidate the main conclusions of the work or involve honest mistakes that cannot be corrected through a corrigendum. Editor- or publisher-initiated retractions generally occur in response to misconduct, ethical violations, plagiarism, or falsified data.
The retraction process follows COPE guidelines, and authors are allowed to respond before the retraction is finalized. Retracted articles are clearly marked, and a link to the retraction notice is provided, ensuring transparency while preserving the integrity and traceability of the scholarly record.
Editor's Notes are published under circumstances that do not call for a retraction, correction, or expression of concern.
These notes draw attention to aspects of a published article that do not influence its results or conclusions, but where editors believe it is appropriate to recommend that readers exercise caution in interpreting the article's content. An Editor's Note is an online-only update, appearing only in the HTML version of the article, and is not indexed.
An Editor’s Note may be warranted, for example, when:
An Editorial Expression of Concern (EEoC) is an official notice released by journal editors to inform readers about potential problems or uncertainties that could affect the credibility or ethical soundness of a published paper. Following the Committee on Publication Ethics (COPE) guidelines, an EEoC may be issued when:
Editorial Expressions of Concern (EEoCs) are published online, connected both ways to the original publication, and provided with their own Digital Object Identifier (DOI). If new information emerges, it could be replaced with a correction, retraction, or clarifying statement, depending on the results of the review. These notices are typically indexed in databases where the journal is listed.
Editor’s Notes and Editorial Expressions of Concern are generally—though not in every instance—replaced by another type of editorial update, such as a correction or a retraction, after the completion of an investigation. While an Editorial Expression of Concern remains a lasting component of the scholarly record, it can be modified or supplemented to incorporate the conclusions once the inquiry has reached its conclusion.
Our Advisory Board members assist in addressing and resolving various aspects pertaining to research ethics and potential publication misconduct.
Authors are advised against extensively citing articles published in the same journal where they intend to publish their own work.
Editors and reviewers are strongly encouraged to refrain from suggesting irrelevant articles to authors as a means to boost their own or the journal’s citation counts.
Scifiniti provides authors with a digital PDF of their published articles, which can be easily shared with colleagues, institutions, or online platforms.
We do not offer physical reprints as part of our standard publishing services. This approach supports open access, broad digital dissemination, and sustainability. Authors can use the PDF and DOI link to distribute their work. For special requests regarding printed copies, please contact the journal office for guidance.
Scifiniti Publishing does not host any advertisements on its journals or website, ensuring that all editorial decisions remain fully independent and unbiased. Our focus is solely on the integrity and quality of scholarly content. Should advertising be introduced in the future, it will be clearly distinguished from editorial material, comply with ethical standards, and never influence peer review or publication decisions.